Clinical features and outcomes of in-hospital cardiac arrest in code blue events: a retrospective observational study

Masayuki Akatsuka1, Hiroomi Tatsumi1, Yoshiki Masuda1

  • 1Department of Intensive Care Medicine, School of Medicine, Sapporo Medical University, Sapporo, Japan.

PubMed

Insights

The Cardiac Arrest Survival Postresuscitation In-Hospital (CASPRI) score accurately predicts survival to hospital discharge in patients experiencing in-hospital cardiac arrest (IHCA) during Code Blue events.

Area of Science:

  • Cardiology
  • Critical Care Medicine
  • Medical Informatics

Background:

  • In-hospital cardiac arrest (IHCA) outcomes are less studied than out-of-hospital events.
  • Code Blue activations represent critical IHCA events requiring focused research.
  • Understanding IHCA epidemiology and prognosis is crucial for improving patient care.

Purpose of the Study:

  • To investigate the epidemiology and prognosis of IHCA in patients with Code Blue activation.
  • To identify predictive factors for survival to hospital discharge (SHD) in IHCA patients.
  • To evaluate the utility of the Cardiac Arrest Survival Postresuscitation In-Hospital (CASPRI) score.

Main Methods:

  • Retrospective observational study of Code Blue events from January 2010 to October 2019.
  • Inclusion of patient and IHCA characteristics, including CPR duration, shockable rhythm, and CASPRI score.
  • Univariate and multivariate logistic regression analyses to determine predictors of SHD.

Main Results:

  • The study enrolled 81 participants from 293 Code Blue events.
  • Overall survival to hospital discharge (SHD) rate was 28.4%.
  • The CASPRI score was identified as the most accurate predictive factor for SHD (OR=0.98, p=0.006).

Conclusions:

  • The CASPRI score is significantly associated with SHD in IHCA patients during Code Blue events.
  • The CASPRI score may serve as a valuable tool for managing post-cardiac arrest syndrome.
  • Further research can explore the integration of CASPRI into clinical management protocols.
Abstract

Related Concept Videos

Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
159
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
177
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
187
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
216
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
167